Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alassane Dicko

Showing results (101-110 of 163) with videos related to

Pageof 17
Sort By:
Malaria Journal|December 6, 2022
Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytesTate Oulton, Almahamoudou Mahamar, Koualy Sanogo, et al.
Vaccine|August 29, 2009
The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in MaliBoubacar Traore, Younoussou Koné, Safiatou Doumbo, et al.
Plos Medicine|August 22, 2020
Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, MaliMatthew E Cairns, Issaka Sagara, Issaka Zongo, et al.
The Journal of Infectious Diseases|January 18, 2018
Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment TrialIngrid Chen, Halimatou Diawara, Almahamoudou Mahamar, et al.
Plos One|September 24, 2016
Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in MaliHamma Maiga, Estrella Lasry, Modibo Diarra, et al.
Communications Biology|November 20, 2021
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinityJonathan P Renn, Justin Y A Doritchamou, Bergeline C Nguemwo Tentokam, et al.
Tropical Medicine & International Health : TM & IH|October 27, 2019
Impact of the addition of azithromycin to antimalarials used for seasonal malaria chemoprevention on antimicrobial resistance of Streptococcus pneumoniaeSoumeya Hema-Ouangraoua, Abdoul Aziz Maiga, Matthew Cairns, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Systemic Inflammatory Response to Malaria During Pregnancy Is Associated With Pregnancy Loss and Preterm DeliveryMichal Fried, Jonathan D Kurtis, Bruce Swihart, et al.
BMJ Open|September 16, 2020
Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01<sub>E</sub> vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemopreventionDaniel Chandramohan, Alassane Dicko, Issaka Zongo, et al.
Malaria Journal|February 9, 2022
Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, MaliAlmahamoudou Mahamar, Kelsey M Sumner, Brandt Levitt, et al.
Pageof 17

Showing results (101-110 of 163) with videos related to

Sort By:
Pageof 17
Malaria Journal|December 6, 2022
Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytesTate Oulton, Almahamoudou Mahamar, Koualy Sanogo, et al.
Vaccine|August 29, 2009
The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in MaliBoubacar Traore, Younoussou Koné, Safiatou Doumbo, et al.
Plos Medicine|August 22, 2020
Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, MaliMatthew E Cairns, Issaka Sagara, Issaka Zongo, et al.
The Journal of Infectious Diseases|January 18, 2018
Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment TrialIngrid Chen, Halimatou Diawara, Almahamoudou Mahamar, et al.
Plos One|September 24, 2016
Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in MaliHamma Maiga, Estrella Lasry, Modibo Diarra, et al.
Communications Biology|November 20, 2021
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinityJonathan P Renn, Justin Y A Doritchamou, Bergeline C Nguemwo Tentokam, et al.
Tropical Medicine & International Health : TM & IH|October 27, 2019
Impact of the addition of azithromycin to antimalarials used for seasonal malaria chemoprevention on antimicrobial resistance of Streptococcus pneumoniaeSoumeya Hema-Ouangraoua, Abdoul Aziz Maiga, Matthew Cairns, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Systemic Inflammatory Response to Malaria During Pregnancy Is Associated With Pregnancy Loss and Preterm DeliveryMichal Fried, Jonathan D Kurtis, Bruce Swihart, et al.
BMJ Open|September 16, 2020
Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01<sub>E</sub> vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemopreventionDaniel Chandramohan, Alassane Dicko, Issaka Zongo, et al.
Malaria Journal|February 9, 2022
Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, MaliAlmahamoudou Mahamar, Kelsey M Sumner, Brandt Levitt, et al.
Pageof 17